UVA Critical Wavelength Testing Plus In Vivo Method Recommended By AAD
This article was originally published in The Rose Sheet
Executive Summary
In vitro critical wavelength testing should be combined with an in vivo method for determining UVA protec- tion in sunscreens, the American Academy of Dermatology opines in a set of "final" recommendations on UVA sunscreen protection published in the March Journal of the American Academy of Dermatology.
You may also be interested in...
UVA Labeling "Pass/Fail" System Least Confusing To Consumers - P&G
UVA sunscreen labeling should be based on a descriptive "pass/fail" system that categorizes products as "broad-spectrum" without designating a specific level of UVA protection, Procter & Gamble Senior Scientist Jay Nash, PhD, suggested.
In Vivo UVA Sunscreen Tests "Clinically Irrelevant...Unethical" - Diffey
The use of in vivo methods for UVA sunscreen testing is "clinically irrelevant" and "unethical," Brian Diffey, PhD, Newcastle General Hospital, maintained at the American Association of Dermatology UVA consensus conference in Washington, D.C. Feb. 4.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program